Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report
Kongfei Li, Yuxiao Wang, RenZhi Pei, Ying Lu, Junjie Cao, Xianxu Zhuang, Jiaying Lian, Bibo ZhangThe Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, China; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, ChinaKeywords: Mixed-phenotype acute leukemia, Targeted therapy, Inotuzumab ozogamicin
Mikst Fenotip Akut Lösemi Tedavisinde Kalikamisin-Inotuzumab Ozogamisin ile Kombine Venetoclax + Azasitidin Rejimi: Olgu Sunumu
Kongfei Li, Yuxiao Wang, RenZhi Pei, Ying Lu, Junjie Cao, Xianxu Zhuang, Jiaying Lian, Bibo ZhangThe Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, China; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, ChinaAnahtar Kelimeler: Mikst fenotip akut lösemi, Hedefe yönelik tedavi, Ýnotuzumab ozogamisin
Kongfei Li, Yuxiao Wang, RenZhi Pei, Ying Lu, Junjie Cao, Xianxu Zhuang, Jiaying Lian, Bibo Zhang. Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report. Turkderm-Turk Arch Dermatol Venereol. 2024; 41(3): 202-204
Corresponding Author: Kongfei Li
Corresponding Author: Kongfei Li
| TOOLS |
 Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Similar articles PubMed Google Scholar |